[1]冉振龙,张海江,陈强,等.康柏西普联合黄斑格栅光凝治疗糖尿病性黄斑水肿的疗效[J].眼科新进展,2020,40(9):845-848.[doi:10.13389/j.cnki.rao.2020.0192]
　RAN Zhenlong,ZHANG Haijiang,CHEN Qiang,et al.The effect of conbercept combined with macular grid photocoagulation on diabetic macular edema[J].Recent Advances in Ophthalmology,2020,40(9):845-848.[doi:10.13389/j.cnki.rao.2020.0192]
点击复制

康柏西普联合黄斑格栅光凝治疗糖尿病性黄斑水肿的疗效/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年9期
页码:
845-848
栏目:
应用研究
出版日期:
2020-09-05

文章信息/Info

Title:
The effect of conbercept combined with macular grid photocoagulation on diabetic macular edema
作者:
冉振龙; 张海江; 陈强; 王丽英; 张月玲
071000　河北省保定市，保定市第一中心医院眼二科
Author(s):
RAN Zhenlong; ZHANG Haijiang; CHEN Qiang; WANG Liying; ZHANG Yueling
The Second Department of Ophthalmology,the First Center Hospital of Baoding City,Baoding 071000,Hebei Province,China
关键词:
糖尿病性黄斑水肿; 康柏西普; 格栅光凝; 光学相干断层扫描血管成像; 多焦视网膜电图
Keywords:
diabetic macular edema;  conbercept;  grid photocoagulation;  optical coherent tomography angiography;  multifocal electroretinogram
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2020.0192
文献标志码:
A
摘要:
目的　应用光学相干断层扫描血管造影（OCTA）与多焦视网膜电图（mf-ERG）评估康柏西普联合黄斑格栅光凝对糖尿病性黄斑水肿（diabetic macular edema，DME）患者黄斑水肿及视力的改善作用，并分析作用机制。方法　选择我院2017年4月至2018年7月DME患者80例，随机分为对照组（40例）和试验组（40例），对照组只进行格栅光凝治疗，试验组同时给予康柏西普眼内给药治疗，分别于治疗前及治疗后1个月、3个月、6个月应用OCTA与mf-ERG检测黄斑及视网膜功能和视力状况，并应用OCT和FFA检测黄斑中心凹厚度及荧光素渗漏状况。结果　两组治疗前与治疗1个月、3个月、6个月后黄斑中心凹无血管区（FAZ）和黄斑区视网膜血管密度比较以及对照组治疗前视力与治疗后比较，差异均无统计学意义（均为P>0.05）；试验组治疗后3个月和6个月时的视力均高于治疗前与同期的对照组，差异均有统计学意义（均为P<0.05）；试验组治疗后3个月、6个月时，mf-ERG的P1、N1波环1、环4反应密度均高于同期对照组，差异均有统计学意义(均为P<0.05)。两组治疗后1个月、3个月、6个月的OCT和FFA结果均优于治疗前，治疗后6个月时的各项指标结果均优于治疗后1个月、3个月，差异均有统计学意义(均为P<0.05)。两组患者间治疗后1个月、3个月、6个月OCT和FFA结果比较，差异均无统计学意义（均为P>0.05）。结论　在黄斑格栅光凝基础上，联合康柏西普眼内注药治疗DME患者，能够显著改善患者黄斑、视网膜结构和功能，提高患者视力水平。
Abstract:
Objective　To evaluate the efficacy of macular grid photocoagulation, combined with conbercept intraocular injection for patients with diabetic macular edema (DME) by optical coherent tomography angiography (OCTA) and multifocal electroretinogram (mf-ERG), and to analyze the mechanism of treatment.Methods　Totally 80 DME patients in hospital from April in 2017 to July in 2018 were enrolled, and they were randomly divided into control group and experimental group, 40 patients in each group. Control group was treated with macular grid photocoagulation, and the experimental group was given conbercept combined with macular grid photocoagulation. OCTA and mf-ERG were used to detect macular and retinal function and visual status before treatment and at 1 month, 3 months, and 6 months after treatment. Macular foveal thickness and fluorescein leakage were detected by optical coherence tomography (OCT) and fluorescein fundus angiography (FFA).Results　There were no significant differences in foveal avascular zone (FAZ) and and macular retinal vascular density between before treatment and 1 month, 3 months, and 6 months after treatment in the both groups, as well as in visual acuity of the control group pre-treatment and post-treatment (all P>0.05). The visual acuity of the experimental group was higher than that of the control group at 3 months and 6 months after treatment and before surgery (P<0.05). The response density of P1 and N1 rings 1 and 4 of mf-ERGs in the experimental group at 3 months, and 6 months after treatment were higher than those in the control group, and the differences were statistically significant (both P<0.05). In the both groups, the results of OCT and FFA 1 month, 3 months, and 6 months after treatment were better than those of before treatment, the results of which after treatment 6 months were better than 1 month and 3 months after treatment, and the differences were statistically significant (all P<0.05). There was no significant difference in OCT and FFA after treatment between the two groups (all P>0.05).Conclusion　Macular grid photocoagulation combined with conbercept intraocular injection for the treatment of DME patients can significantly improve the patient’s macular, retinal structure and function, and visual acuity.

参考文献/References:

［1］MEHMET T,ZAFER Y,SERDAR A,HACI M S,FATIH O.VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema［J］.Int Ophthalmol,2018,38(6):2381-2388.
［2］　卢谦益.阿柏西普经玻璃体内注射治疗糖尿病黄斑水肿的临床疗效［J］.眼科新进展,2019,39(4):340-342.
LU Q Y.Intravitreal aflibercept injection for the treatment of diabetic macular edema［J］.Rec Adv Ophthalmol,2019,39(4):340-342.
［3］　黄超,赵永,王梅,喻亚梅.OCT 血管成像术在中心性渗出性脉络膜视网膜病变中的应用［J］.临床眼科杂志,2019,27(2):118-121.
HUANG C,ZHAO Y,WANG M,YU Y M.Application of OCT angiography in central exudative chorioretinopathy［J］.J Clin Ophthalmol,2019,27(2):118-121.
［4］　季玲,陈婷妍,梁勇.糖尿病性黄斑水肿的早期诊断与治疗［J］.国际眼科杂志,2014,14(10):1809-1811.
JI L,CHEN T Y,LIANG Y.Early diagnosis and treatment of diabetic macular edema［J］.Int Eye Sci,2014,14(10):1809-1811.
［5］　张召弟,郭晟,帅天姣,朴天华.玻璃体内注射康柏西普对弥漫性糖尿病性黄斑水肿的影响［J］.眼科新进展,2018,38(1):69-72.
ZHANG Z D,GUO S,SHUAI T J,PIAO T H.Effect of intravitreal injection of conbercept on diabetic diffuse macular edema［J］.Rec Adv Ophthalmol,2018,38(1):69-72.
［6］　田秀红.黄斑区格栅样光凝与玻璃体腔注射雷珠单抗治疗糖尿病黄斑水肿的疗效观察［J］.中国处方药,2017,15(7):76-77.
TIAN X H.Effect of grille-like photocoagulation in macular area and intravitreal injection of Leizhu McAb on diabetic macular edema［J］.J China Prescr Drug,2017,15(7):76-77.
［7］　NIMET Y E,SERHAT I,ESRA T K,NURSAL M Y,HANDAN B,YAVUZ B.Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema［J］.Cutan Ocul Toxicol,2018,37(4):324-327.
［8］　刘彦,陈建华,赵慧英,吴香丽,殷英霞,陈冬军.康柏西普玻璃体腔注射联合激光光凝对糖尿病黄斑水肿患者脉络膜厚度的影响［J］.陕西医学杂志,2019,48(8):1063-1066.
LIU Y,CHEN J H,ZHAO H Y,WU X L,YIN Y X,CHEN D J.Clinical observation of intravitreal injection of Conbercept combined with laser photocoagulation for diabetic macular edema［J］.Shaanxi Med J,2019,48(8):1063-1066.
［9］　陈震,许阿敏,夏沁韵.玻璃体内注射阿柏西普治疗糖尿病黄斑水肿的疗效［J］.武汉大学学报（医学版）,2019,40(5):842-844.
CHEN Z,XU A M,XIA Q Y.Intravitreal injection of Aflibercept for the treatment of diabetic macular edema［J］.Med J Wuhan Univ,2019,40(5):842-844.
［10］　宋爱萍,于涛,卓建,曲鹏.近视患者黄斑区视网膜多焦视网膜电图和光学相干断层扫描的评估和分析［J］.眼科新进展,2019,39(3):255-259.
SONG A P，YU T，ZHUO J，QU P.Evaluation and analysis of macular retina by multifocal electroretinogram and optical coherence tomography in myopia［J］.Rec Adv Ophthalmol,2019,39(3):255-259.
［11］　孙沅,王健,孙沂,张晓梅，魏海英，葛亮.OCTA用于检测不同屈光人群的黄斑区视网膜密度和厚度及其相关性分析［J］.现代生物医学进展,2019,19(14):2797-2800.
SUN Y,WANG J,SUN Y,ZHANG X M,WEI H Y,GE L.Detection and Correlative Analysis of the Retinal Density and Thickness in the Macular Area in Patients with Different Refractive Light［J］.Prog Mod Biomed,2019,19(14):2797-2800.
［12］　BALARATNASINGAM C,MAIKO I,SEUNGJUN A,JESSE M,ELONA D G,LAWRENCE A Y,et al.Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion［J］.Ophthalmology,2016,123(11):2352-2367.
［13］　GONG D,YU W H,ZHANG X,YANG,Z K,ZOU X,QU Y,et al.A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography［J］.Graefes Arch Clin Exp Ophthalmol,2016,254(5):873-879.
［14］　TAKASE N,NOZAKI M,KATO A,OZEKI H,YOSHIDA M,OGURA Y.Enlargement of foveal avascular zone in diabaetic eyes evalyatde by en face optical coherence tomography angiography［J］.Retina,2015,35(11):2377-2383.
［15］　LITTLEWOOD,MOLLAN,PAPPER,HICKMAN.The utility of fundus fluorescein angiography in neuro-ophthalmology［J］.Neuroophthalmology,2019,43(4):217-234.
［16］　刘景祥,姜玉莹,陈丽丽,李林.FFA联合黄斑OCT在糖尿病性视网膜病变诊断及评价疗效中的应用［J］.中国实验诊断学,2016,20(8):1287-1288．
LIU J X,JIANG Y Y,CHEN L L,LI L.FFA combined with macular OCT in diagnosis and evaluation of diabetic retinopathy［J］.Chin J Lab Diagn,2016,20(8):1287-1288．
［17］　齐佳,郭蕊,周云,代琴.应用多焦视网膜电图进行激光治疗糖尿病视网膜病变的临床研究［J］.临床眼科杂志,2017,25(2):125-128.
QI J,GUO R,ZHOU Y,DAI Q.The clinical study of laser treatment of diabetic retinopathy with multi focus［J］.J Clin Ophthalmol,2017,25(2):125-128.

相似文献/References:

[1]麻南 李丹 高付林 胡莲娜.玻璃体内注射贝伐单抗和贝伐单抗/曲安奈德联合用药治疗糖尿病性黄斑水肿疗效及安全性差异的荟萃分析[J].眼科新进展,2012,32(6):000.
[2]王玲,生侠,吴清静,等.红外线及自发荧光影像在糖尿病性黄斑水肿诊断中的价值[J].眼科新进展,2014,34(8):754.[doi:10.13389/j.cnki.rao.2014.0207]
　WANG Ling,SHENG Xia,WU Qing-Jing,et al.Value of infrared ray and auto fluorescence in diagnosis of diabetic macular edema[J].Recent Advances in Ophthalmology,2014,34(9):754.[doi:10.13389/j.cnki.rao.2014.0207]
[3]杨宇,田敏,吕红彬. 糖尿病视网膜病变的治疗进展[J].眼科新进展,2015,35(5):497.[doi:10.13389/j.cnki.rao.2015.0136]
　YANG Yu,TIAN Min,LV Hong-Bin. Recent advances in treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(9):497.[doi:10.13389/j.cnki.rao.2015.0136]
[4]李素华,高永峰. 比较单独黄斑局灶/格栅样光凝术和联合雷珠单抗治疗糖尿病性黄斑水肿的疗效[J].眼科新进展,2015,35(6):566.[doi:10.13389/j.cnki.rao.2015.0153]
　LI Su-Hua,GAO Yong-Feng. Efficacy of macular focal / grid photocoagulation combined with ranibizumab for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(9):566.[doi:10.13389/j.cnki.rao.2015.0153]
[5]夏风杰,闫峰,陆燕,等.糖尿病性黄斑水肿临床治疗进展[J].眼科新进展,2015,35(10):985.[doi:10.13389/j.cnki.rao.2015.0270]
　XIA Feng-Jie,YAN Feng,LU Yan,et al.Clinical treatment advances in diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(9):985.[doi:10.13389/j.cnki.rao.2015.0270]
[6]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
　ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(9):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[7]李秀云,朱艳,邓爱军.Ranibizumab治疗糖尿病性黄斑水肿短期疗效观察[J].眼科新进展,2016,36(1):067.[doi:10.13389/j.cnki.rao.2016.0019]
　LI Xiu-Yun,ZHU Yan,DENG Ai-Jun.Short-term efficacy of Ranibizumab for diabetic macular edema[J].Recent Advances in Ophthalmology,2016,36(9):067.[doi:10.13389/j.cnki.rao.2016.0019]
[8]陈素芳,李亨辉,邵毅,等.非诺贝特在糖尿病性黄斑水肿中的临床研究[J].眼科新进展,2016,36(2):136.[doi:10.13389/j.cnki.rao.2016.0037]
　CHEN Su-Fang,LI Heng-Hui,SHAO Yi,et al.Clinical study of fenofibrate in diabetic macular edema[J].Recent Advances in Ophthalmology,2016,36(9):136.[doi:10.13389/j.cnki.rao.2016.0037]
[9]李娜,张杰,高荣玉,等.单次注射康柏西普治疗渗出型AMD患者RPE隆起面积与容积变化[J].眼科新进展,2016,36(2):172.[doi:10.13389/j.cnki.rao.2016.0047]
　LI Na,ZHANG Jie,GAO Rong-Yu,et al.Changes of retinal pigment epithelium uplift area and volume in exudative age-related macular degeneration after once injection of conbercept[J].Recent Advances in Ophthalmology,2016,36(9):172.[doi:10.13389/j.cnki.rao.2016.0047]
[10]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471.[doi:10.13389/j.cnki.rao.2016.0126]
　WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(9):471.[doi:10.13389/j.cnki.rao.2016.0126]
[11]宋志刚,魏少华.577 nm激光光凝联合玻璃体内注射康柏西普治疗糖尿病性黄斑水肿的效果观察[J].眼科新进展,2019,39(4):373.[doi:10.13389/j.cnki.rao.2019.0085]
　SONG Zhi-Gang,WEI Shao-Hua.Effect of 577 nm laser photocoagulation combined with intravitreal injection of conbercept on diabetic macular edema[J].Recent Advances in Ophthalmology,2019,39(9):373.[doi:10.13389/j.cnki.rao.2019.0085]
[12]马若璇,冉振龙,张月玲,等.玻璃体内注射康柏西普对糖尿病性黄斑水肿患者黄斑区视网膜血管密度和中心凹无血管区面积的影响[J].眼科新进展,2020,40(4):365.[doi:10.13389/j.cnki.rao.2020.0084]
　MA Ruoxuan,RAN Zhenlong,ZHANG Yueling,et al.Effect of intravitreal injection of Conbercept for treatment of diabetic macular edema on retinal vessel density at macular region and foveal avascular zone area[J].Recent Advances in Ophthalmology,2020,40(9):365.[doi:10.13389/j.cnki.rao.2020.0084]
[13]宋泽娟,徐静,李婵.羟苯磺酸钙联合康柏西普治疗糖尿病性黄斑水肿的疗效和安全性[J].眼科新进展,2021,41(1):075.[doi:10.13389/j.cnki.rao.2021.0016]
　SONG Zejuan,XU Jing,LI Chan.Clinical efficacy and safety of calcium dobesilate combined with conbercept in the treatment of diabetic macular edema[J].Recent Advances in Ophthalmology,2021,41(9):075.[doi:10.13389/j.cnki.rao.2021.0016]
[14]邓爱萍,田润,熊成,等.地塞米松玻璃体内植入剂早期联合康柏西普在抗血管内皮生长因子治疗反应不佳糖尿病性黄斑水肿中的应用[J].眼科新进展,2023,43(9):722.[doi:10.13389/j.cnki.rao.2023.0145]
　DENG Aiping,TIAN Run,XIONG Cheng,et al.Application of intravitreal dexamethasone implant combined with Conbercept in the treatment of diabetic macular edema with poor response to anti-vascular endothelial growth factor therapy[J].Recent Advances in Ophthalmology,2023,43(9):722.[doi:10.13389/j.cnki.rao.2023.0145]

备注/Memo

备注/Memo:
保定市科学研究与发展计划项目（编号：16ZF114）
更新日期/Last Update: 2020-09-05